Prediction of Adverse Drug Reactions Using Decision Tree Modeling
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drug safety is of great importance to public health. The detrimental effects of drugs not only limit their application but also cause suffering in individual patients and evoke distrust of pharmacotherapy. For the purpose of identifying drugs that could be suspected of causing adverse reactions, we present a structure-activity relationship analysis of adverse drug reactions (ADRs) in the central nervous system (CNS), liver, and kidney, and also of allergic reactions, for a broad variety of drugs (n = 507) from the Swiss drug registry. Using decision tree induction, a machine learning method, we determined the chemical, physical, and structural properties of compounds that predispose them to causing ADRs. The models had high predictive accuracies (78.9-90.2%) for allergic, renal, CNS, and hepatic ADRs. We show the feasibility of predicting complex end-organ effects using simple models that involve no expensive computations and that can be used (i) in the selection of the compound during the drug discovery stage, (ii) to understand how drugs interact with the target organ systems, and (iii) for generating alerts in postmarketing drug surveillance and pharmacovigilance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Similarity-based virtual screening using 2D fingerprints
Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849 · cited 1×
“We used the Tanimoto coefficient 10 as a measure of similarity (see Supplementary Data online). dti.”
Method
Cited by
An Introduction to Machine Learning
Badillo, S., Banfai, B., Birzele, F., Davydov, I. I., Hutchinson, L., Kam‐Thong, T., Siebourg‐Polster, J., Steiert, B., & Zhang, J. D. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1796 · Cited by 799
Role of artificial intelligence in patient safety outcomes: systematic literature review
Choudhury, A., & Asan, O. (2020) · JMIR Medical Informatics · doi:10.2196/18599 · Cited by 440
Liu, M., Wu, Y., Chen, Y., Sun, J., Zhao, Z., Chen, X.-W., Matheny, M. E., & Xu, H. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000699 · Cited by 289
In silico repositioning of approved drugs for rare and neglected diseases
Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288
Artificial intelligence for drug discovery: Resources, methods, and applications
Chen, W., Liu, X., Zhang, S., & Chen, S. (2023) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2023.02.019 · Cited by 273
Artificial intelligence in the field of pharmacy practice: A literature review
Chalasani, S. H., Syed, J., Ramesh, M., Patil, V., & Pramod Kumar, T. M. (2023) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2023.100346 · Cited by 162
“11,12 In a study by Cami et al., a logistic regression classifier to predict unknown ADRs for marketed drugs using structural properties of the drug-ADR network as well as chemical and taxonomic properties of drugs as features was developed.”
BackgroundWong, A., Amato, M. G., Seger, D. L., Rehr, C., Wright, A., Slight, S. P., Beeler, P. E., Orav, E. J., & Bates, D. W. (2018) · BMJ Quality & Safety · doi:10.1136/bmjqs-2017-007531 · Cited by 77
“24 25 Additionally, our EHR and CDS system can differentiate between a true medication allergy and that of intolerance.”
BackgroundPredicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases
Zheng, Y., Peng, H., Zhang, X., Zhao, Z., Yin, J., & Li, J. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2520-8 · Cited by 33
Metadata
- Authors
- Hammann, F., Gutmann, H., Vogt, N., Helma, C., & Drewe, J.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-03-10
- Volume
- 88
- Issue
- 1
- Pages
- 52-59
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2000127653
- Cited by
- 109
- References
- 2
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.